Pacer Advisors, Inc. Collegium Pharmaceutical, Inc Transaction History

Pacer Advisors, Inc.

$40.5 Billion
Q4 2024

A detailed history of Pacer Advisors, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 2,142,491 shares of COLL stock, worth $68.2 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

2,142,491

Previous 2,589,648 17.27%

Holding current value

$68.2 Million

Previous $100 Million 38.66%

% of portfolio

0.15%

Previous 0.24%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	SELL	$28.61 - $41.86 $12.8 Million - $18.7 Million	-447,157 Reduced 17.27%	2,142,491 $61.4 Million
Q3 2024 Nov 12, 2024	SELL	$31.4 - $39.07 $25.7 Million - $32 Million	-818,721 Reduced 24.02%	2,589,648 $100 Million
Q2 2024 Aug 13, 2024	BUY	$31.36 - $39.99 $25.8 Million - $32.9 Million	821,541 Added 31.76%	3,408,369 $110 Million
Q1 2024 May 10, 2024	BUY	$31.23 - $40.91 $12.9 Million - $16.9 Million	412,110 Added 18.95%	2,586,828 $100 Million
Q4 2023 Jan 16, 2024	BUY	$21.16 - $30.8 $18.7 Million - $27.2 Million	883,380 Added 68.41%	2,174,718 $66.9 Million
Q3 2023 Nov 13, 2023	BUY	$21.23 - $24.28 $10.9 Million - $12.4 Million	511,692 Added 65.63%	1,291,338 $28.9 Million
Q2 2023 Jul 12, 2023	BUY	$21.06 - $24.0 $7.09 Million - $8.09 Million	336,879 Added 76.08%	779,646 $16.8 Million
Q1 2023 May 02, 2023	BUY	$23.0 - $29.88 $3.25 Million - $4.23 Million	141,458 Added 46.95%	442,767 $10.6 Million
Q4 2022 Feb 06, 2023	BUY	$16.14 - $23.55 $4.86 Million - $7.1 Million	301,309 New	301,309 $6.99 Million
Q2 2022 Aug 12, 2022	SELL	$14.22 - $20.88 $3.14 Million - $4.61 Million	-220,982 Closed	0 $0
Q1 2022 Apr 05, 2022	BUY	$17.2 - $22.5 $1.29 Million - $1.69 Million	75,090 Added 51.47%	220,982 $4.5 Million
Q4 2021 Feb 03, 2022	BUY	$17.5 - $21.35 $692,265 - $844,563	39,558 Added 37.2%	145,892 $2.73 Million
Q3 2021 Oct 15, 2021	BUY	$17.75 - $25.39 $282,793 - $404,513	15,932 Added 17.62%	106,334 $2.1 Million
Q2 2021 Jul 21, 2021	BUY	$21.74 - $25.28 $1.97 Million - $2.29 Million	90,402 New	90,402 $2.14 Million

Others Institutions Holding COLL

# of Institutions

248

Shares Held

36.2M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.09B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Collegium Pharmaceutical, Inc Transaction History